Shandra Wilson, MD
Urology · Greenwood Village, CONPI 1275557043
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (31.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Intuitive Surgical at 41.7% of the total. Reporting peaked in 2019 at $4,171 and has fallen 97.2% since, to $118 in 2024.
Across 95 payments — averaging $90.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Shionogi Inc$2K
- Coloplast$906
- Novartis$378
- Boston Scientific$342
- Covidien LP$335
- plus $1K from 21 others
What the payments were for
- Consulting fees$2,33527%
- Travel & lodging$2,58530%
- Food & beverage$2,68731%
- Education$1,00012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $3,589 |
| Shionogi Inc | 1 | $2,000 |
| Coloplast | 12 | $906 |
| Novartis | 4 | $378 |
| Boston Scientific | 11 | $342 |
| Covidien LP | 1 | $335 |
| Astellas Pharma US Inc | 12 | $211 |
| Spinal Simplicity, LLC | 1 | $103 |
| Procept Biorobotics Corporation | 1 | $92 |
| Antares Pharma, Inc. | 5 | $79 |
| Pfizer | 2 | $53 |
| Axonics, Inc. | 2 | $45 |
| Urogen Pharma, Inc. | 3 | $44 |
| Merck | 1 | $44 |
| Teleflex LLC | 2 | $42 |
| Dendreon Pharmaceuticals LLC | 1 | $38 |
| Ambu Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Hollister Incorporated | 2 | $37 |
| Convatec Inc. | 2 | $33 |
| Myovant Sciences Inc. | 2 | $31 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $28 |
| Telix Pharmaceuticals | 1 | $23 |
| Innovation Technologies Inc | 1 | $22 |
| Amgen | 1 | $21 |
| Photocure Inc | 1 | $21 |
| Laborie Medical Technologies Corp. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,282
- Symproic$2,000
- DAVINCI XI$1,000
- ALTIS$578
- RESTORELLE$135
- GENERAL - THERAPIES$124
- MEKINIST$104
- HA MINUTEMAN G3-R$103
How this compares
$8,607 in reported general payments places this provider in the 75th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 121 | $118,170 |
| GemtesaVibegron | 22 | $24,150 |
| Testosterone | 21 | $7,214 |
| Tamsulosin Hcl | 246 | $2,920 |
| Methenamine Hippurate | 16 | $1,181 |
| Oxybutynin Chloride | 38 | $861 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 36 | $846 |
| Finasteride | 40 | $597 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $386 |
| Solifenacin Succinate | 13 | $362 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 68 | $308 |
| Ciprofloxacin Hcl | 42 | $261 |
| Levofloxacin | 41 | $228 |
| CefuroximeCefuroxime Axetil | 14 | $195 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $194 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $211 | $118,170121 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $38 | $24,15022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 225 urology providers in Colorado.
Other urology in Greenwood Village
- Lawrence KarshDenver$706K
- Alexandra RogersLafayette$476K
- Derek ZukoskyGolden$442K
- James McBrideDurango$234K
- Damian SorceParker$224K
- Suzanne MerrillLone Tree$102K
- Ali SarramLone Tree$76K
- John KeferBoulder$68K
- Garrick GreearLongmont$62K
- Nicholas WestfallGrand Junction$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.